NCT03822624

Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic Dermatitis

Randomized, Double Blind, Placebo Controlled Study to Evaluate Efficiency and Safety on the Use of a Probiotic in SCORAD Reduction in 4-to-17 Years-old Patients With Atopic Dermatitis

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Biopolis S.L. · Industry
• Sex: All
• Age: 4 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

The study's objective is to confirm that an oral probiotic treatment reduces the signs and symptoms of moderate atopic dermatitis determined by SCORAD, in patients aged 4 to 17 years, as compared to placebo. It will also be examined if the probiotic treatment, as compared to placebo, reduces the quantity of topical steroids used to treat disease flares, and increases the time till the first disease flare after the end of treatment.

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	Probiotic mixture with three bacterial strains with maltodextrin as a carrier.
OTHER	Placebo	Placebo comparator with maltodextrin as a carrier.

Timeline

• Start date: 2018-05-23
• Primary completion: 2019-05-01
• Completion: 2019-09-01
• First posted: 2019-01-30
• Last updated: 2019-02-05

Locations

3 sites across 1 country: Spain